Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

White matter hyperintensities in mild lewy body dementia.

Oppedal K, Aarsland D, Firbank MJ, Sonnesyn H, Tysnes OB, O'Brien JT, Beyer MK.

Dement Geriatr Cogn Dis Extra. 2012 Jan;2(1):481-95. doi: 10.1159/000343480.

2.

Cognitive and structural magnetic resonance imaging features of Lewy body dementia and Alzheimer's disease.

Rodriguez MJ, Potter E, Shen Q, Barker W, Greig-Custo M, Agron J, Loewenstein D, Duara R.

Alzheimers Dement. 2012 May;8(3):211-8. doi: 10.1016/j.jalz.2011.04.008.

PMID:
22546353
3.

Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging.

Gootjes L, Teipel SJ, Zebuhr Y, Schwarz R, Leinsinger G, Scheltens P, Möller HJ, Hampel H.

Dement Geriatr Cogn Disord. 2004;18(2):180-8.

PMID:
15211074
4.

Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease.

Chen YF, Wang H, Chu Y, Huang YC, Su MY.

Dement Geriatr Cogn Disord. 2006;22(2):177-84.

PMID:
16912479
5.

Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease.

Kim JH, Hwang KJ, Kim JH, Lee YH, Rhee HY, Park KC.

J Clin Neurosci. 2011 Aug;18(8):1101-6. doi: 10.1016/j.jocn.2011.01.008.

PMID:
21723730
6.

Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.

Shim YS, Youn YC, Na DL, Kim SY, Cheong HK, Moon SY, Park KW, Ku BD, Lee JY, Jeong JH, Kang H, Kim EJ, Lee JS, Go SM, Kim SH, Cha KR, Seo SW.

Eur Neurol. 2011;66(2):75-82. doi: 10.1159/000329277.

PMID:
21778730
7.

White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease.

Capizzano AA, Ación L, Bekinschtein T, Furman M, Gomila H, Martínez A, Mizrahi R, Starkstein SE.

J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):822-7.

8.

White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.

Dalaker TO, Larsen JP, Dwyer MG, Aarsland D, Beyer MK, Alves G, Bronnick K, Tysnes OB, Zivadinov R.

Neuroimage. 2009 Oct 1;47(4):2083-9. doi: 10.1016/j.neuroimage.2009.06.020.

PMID:
19539037
9.

Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.

Smith EE, Egorova S, Blacker D, Killiany RJ, Muzikansky A, Dickerson BC, Tanzi RE, Albert MS, Greenberg SM, Guttmann CR.

Arch Neurol. 2008 Jan;65(1):94-100. doi: 10.1001/archneurol.2007.23.

PMID:
18195145
10.

Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.

Gouw AA, Seewann A, Vrenken H, van der Flier WM, Rozemuller JM, Barkhof F, Scheltens P, Geurts JJ.

Brain. 2008 Dec;131(Pt 12):3286-98. doi: 10.1093/brain/awn265.

11.

White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging.

Barber R, Scheltens P, Gholkar A, Ballard C, McKeith I, Ince P, Perry R, O'Brien J.

J Neurol Neurosurg Psychiatry. 1999 Jul;67(1):66-72.

12.

White matter hyperintensities in dementia: does it matter?

Wahlund LO, Basun H, Almkvist O, Andersson-Lundman G, Julin P, Sääf J.

Magn Reson Imaging. 1994;12(3):387-94.

PMID:
8007767
13.

Visual rating of white matter hyperintensities in Parkinson's disease.

Beyer MK, Aarsland D, Greve OJ, Larsen JP.

Mov Disord. 2006 Feb;21(2):223-9.

PMID:
16161159
14.

Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia.

Doddy RS, Massman PJ, Mawad M, Nance M.

Neuropsychiatry Neuropsychol Behav Neurol. 1998 Oct;11(4):191-9.

PMID:
9845410
15.

Clinical Lewy body dementia and the impact of vascular components.

Londos E, Passant U, Brun A, Gustafson L.

Int J Geriatr Psychiatry. 2000 Jan;15(1):40-9.

PMID:
10637403
16.

White matter hyperintensities and the course of depressive symptoms in elderly people with mild dementia.

Soennesyn H, Oppedal K, Greve OJ, Fritze F, Auestad BH, Nore SP, Beyer MK, Aarsland D.

Dement Geriatr Cogn Dis Extra. 2012 Jan;2:97-111. doi: 10.1159/000335497.

17.

Neuropsychological performance in Lewy body dementia and Alzheimer's disease.

Walker Z, Allen RL, Shergill S, Katona CL.

Br J Psychiatry. 1997 Feb;170:156-8.

PMID:
9093505
18.

White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity.

Scheltens P, Barkhof F, Valk J, Algra PR, van der Hoop RG, Nauta J, Wolters EC.

Brain. 1992 Jun;115 ( Pt 3):735-48.

PMID:
1628199
19.

Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates.

Mulugeta E, Londos E, Hansson O, Ballard C, Skogseth R, Minthon L, Blennow K, Zetterberg H, Aarsland D.

Int J Alzheimers Dis. 2011;2011:495025. doi: 10.4061/2011/495025.

20.

[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].

Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S.

Encephale. 2003 May-Jun;29(3 Pt 1):266-72. French.

PMID:
12876552
Items per page

Supplemental Content

Support Center